Patent US3891635A successfully refreshed from Google Patents.
← Back to Patent Explorer
US3891635A Expired / Lapsed US ⏱️ 0.0 years remaining

7-{8 3-(Phenyl)-isoxazol-5-yl{9 acetamido-cephalosporanic acids

Assignee: DSM Delft BV
•
Filing: 1971-11-03
•
Granted: 1975-06-24
•
Expires: 1991-11-03
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Novel heterocyclic amides of the formula WHEREIN R is selected from the group consisting of lower alkyl and aryl optionally substituted with at least one member of the group consisting of chlorine, fluorine, nitro, amino and lower alkyl and a tertiary alkyl group, R1 is selected from the group consisting of hydrogen, lower alkyl, carboxyl, lower alkoxycarbonyl, an alkali metal, alkaline earth metal or amine salt of carboxyl, a carbamyl, cyano, an amino and chlorine, R2 is selected from the group consisting of hydrogen, cyano, halogen, an amino, lower aralkoxycarbonylamino, lower alkyl, carboxyl esterified with lower alkyl, aryl or aralkyl and carbamoyl optionally substituted on the nitrogen atom with lower alkyl or a phenyl and Q is selected from the group consisting of X is selected from the group consisting of hydrogen, hydroxy and lower alkanoyloxy and U is selected from the group consisting of amido forming groups or a group OY, wherein Y is selected from the group consisting of hydrogen, salt forming groups, and ester forming groups, or COOY and CH2X together form a lactone or lactam, having antibacterial properties, their preparation and novel intermediates thereof.

Inventors

  • 👤 Peter Wolfgang Henniger
  • 👤 Peter Max Smid

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-04 20:28
CPC Classifications
C; C07; C07D; C07D261/00; C07D261/02; C07D261/06; C07D261/08; A; A61; A61P; A61P31/00; A61P31/04; C07D499/00

Claims Analysis

Total Claims: 11
Claim 1
Independent Claim 5 words
A COMPOUND OF THE FORMULA
Claim 2
Dependent Claim 5 words
A COMPOUND OF THE FORMULA
Claim 3
Dependent Claim 43 words
A compound of claim 1 wherein R is selected from the group consisting of 2,6-dichlorophenyl and 2-chloro-6-fluorophenyl, R1 and R2 are selected from thE group consisting of hydrogen and methyl, Q is a cephalosporanic acid nucleus and pharmaceutically acceptable salts of said acids.
Claim 4
Dependent Claim 19 words
A compound of claim 1 selected from the group consisting of 7-((3-(2,6-dichlorophenyl)-isoxazol-5-yl)acetamido)cephalosporanic acid and its non-toxic, pharmaceutically acceptable salts.
Claim 5
Dependent Claim 19 words
A compound of claim 1 selected from the group consisting of 7-((3-(2,6-dichlorophenyl)isoxazol-5-yl)acetamido)desacetoxycephalosporanic acid and its non-toxic, pharmaceutically acceptable salts.
Claim 6
Dependent Claim 20 words
A compound of claim 1 selected from the group consisting of 7-((3-(2,4,6-trimethyl)phenyl-isoxazol-5-yl) acetamido)cephalosporanic acid and its non-toxic, pharmaceutically acceptable salts.
Claim 7
Dependent Claim 20 words
A compound of claim 1 selected from the group consisting of 7-((3-(2,6-dichloro)phenyl-4-methyl-isoxazol-5 -yl)acetamido)desacetoxycephalosporanic acid and its non-toxic, pharmaceutically acceptable salts.
Claim 8
Dependent Claim 20 words
A compound of claim 1 selected from the group consisting of 7-((3-(2,4,6-trimethyl)phenyl-4-methyl-isoxazol-5 -yl)acetamido)cephalosporanic acid and its non-toxic pharmaceutically acceptable salts.
Claim 9
Dependent Claim 20 words
A compound of claim 1 selected from the group consisting of 7-((3-(2,4,6-trimethyl)phenyl-4-methyl-isoxazol-5-yl)acetamido)desacetoxy -cephalosporanic acid and its non-toxic, pharmaceutically acceptable salts.
Claim 10
Dependent Claim 20 words
A compound of claim 1 selected from the group consisting of 7-((3-(4-nitro)phenyl-isoxazol-5-yl)acetamido) cephalosporanic acid and its non-toxic, pharmaceutically acceptable salts.
Claim 11
Dependent Claim 45 words
A compound of claim 1 wherein R is selected from the group consisting of 2,6-dichlorophenyl and 2,4,6-trimethylphenyl, R1 is selected from the group consisting of hydrogen, chlorine, and lower alkyl and R2 is selected from the group consisting of hydrogen, chlorine, amino and lower alkyl.

References Cited (Backward Citations)

US3218318A Cited
US3459746A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1978-06-23 1978-12-23 1979-06-24 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1982-06-23 1982-12-23 1983-06-24 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1986-06-23 1986-12-23 1987-06-24 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag